• Federal Circuit Hears Arguments in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.
  • October 25, 2016 | Author: Surendra K. Ravula
  • Law Firm: Banner & Witcoff, Ltd. - Chicago Office
  • On October 4, 2016, the U.S. Court of Appeals for the Federal Circuit heard oral arguments in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc., case number 16-1284. The Court’s ruling in this case could ultimately affect the way in which invalidating sales and offers for sale as well as other types of prior art enumerated in 35 U.S.C. § 102 of the America Invents Act (AIA) are interpreted.